Syndax Pharmaceuticals (SNDX) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to a loss of $0.98 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +17.95%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.64 per share when it actually produced a loss of $0.78, delivering a surprise of -21.88%.Over the last four quart ...